BioCentury
ARTICLE | Company News

Gen-Probe, Prodesse deal

October 12, 2009 7:00 AM UTC

Gen-Probe will acquire molecular diagnostic company Prodesse for $60 million in cash on hand, plus up to $25 million in potential milestones. Prodesse markets infectious disease diagnostics, including the ProFlu+ real-time PCR test to detect influenza A virus, influenza B virus and respiratory syncytial virus (RSV), and RT-PCR assays for Clostridium difficile and human metapneumovirus. Gen-Probe expects the deal to add $15 million in revenues for 2010. ...